CAS: 1628838-42-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | RAF709 REF: IN-DA00ASTPCAS: 1628838-42-5 | 98% | To inquire | Thu 23 Jan 25 |
 | RAF709 REF: 54-BISN0207CAS: 1628838-42-5 | 99.8% (Typical Value in Batch COA) | 53.00 €~228.00 € | Fri 24 Jan 25 |
 | RAF709 REF: TM-T3711CAS: 1628838-42-5 | 99.43% - 99.83% | 40.00 €~1,287.00 € | Thu 30 Jan 25 |
 | RAF709 REF: 3D-DQC83842CAS: 1628838-42-5 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA00ASTP
| 1mg | 108.00 € | ||
| 50mg | 168.00 € | ||
| 100mg | 282.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025
RAF709
CAS:1628838-42-5
Formula:
C28H29F3N4O4
Purity:
99.8% (Typical Value in Batch COA)
Color and Shape:
white solid
Molecular weight:
542.55g/mol
Ref: 54-BISN0207
| 1mg | 53.00 € |
Estimated delivery in United States, on Friday 24 Jan 2025
RAF709
CAS:1628838-42-5
RAF709 is a novel Raf kinase inhibitor with IC50s of 0.5 and 1.8 nM for …
Formula:
C28H29F3N4O4
Purity:
99.43% - 99.83%
Color and Shape:
Solid
Molecular weight:
542.55
Ref: TM-T3711
| 1mg | 40.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 86.00 € | ||
| 10mg | 130.00 € | ||
| 25mg | 256.00 € | ||
| 50mg | 419.00 € | ||
| 100mg | 618.00 € | ||
| 500mg | 1,287.00 € | ||
| 1mL*10mM (DMSO) | 93.00 € |
Estimated delivery in United States, on Thursday 30 Jan 2025
RAF709
CAS:1628838-42-5
RAF709 is a small molecule that is effective against cancer cells in vitro and in …
Formula:
C28H29F3N4O4
Purity:
Min. 95%
Molecular weight:
542.55 g/mol
Ref: 3D-DQC83842
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
